<DOC>
	<DOC>NCT02514499</DOC>
	<brief_summary>The overall goal of the proposed research is to evaluate the uptake of testing and longitudinal risks and benefits of multiplex testing for cancer susceptibility in BRCA1/2 negative patients. This model will inform the selection of the outcomes and potential mediators and moderators of these outcomes, to inform the debate over utility, risks, and benefits of clinical incorporation of multiplex testing for breast cancer susceptibility.</brief_summary>
	<brief_title>Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study</brief_title>
	<detailed_description />
	<criteria>1. Women and men (at least 18 YO) 2. English speaking AND 3. Negative for BRCA1 and BRCA2 mutations 1. Non English speaking patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>patients</keyword>
</DOC>